Home » Market News » DirectorsTalk Highlights » CERN Technology Next Generation Cancer Treatment
Advanced Oncotherapy Plc

CERN Technology Next Generation Cancer Treatment

STFC and Advanced Oncotherapy (LON:AVO) are collaborating in the construction of a proton therapy assembly and test facility at STFC’s Daresbury Laboratory, that will build on the technology at the heart of the Large Hadron Collider to develop treatments for patients with cancer.

Proton beams targeted precisely at cancerous tumours will limit damage to surrounding organs or tissue, produce fewer side effects and also offer the potential for higher disease-free survival rates. This therapy is most often used to treat brain tumours in young children whose organs and tissues are still developing, or cancers adjacent to critical part of the body (liver, lung, head and neck, prostate, breast).

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.